FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

16 results

auryxia
(ferric citrate)
Akebia Therapeutics, Inc.
Usage: Auryxia is indicated for controlling serum phosphorus levels in adults with chronic kidney disease on dialysis and for treating iron deficiency anemia in adults with chronic kidney disease not on dialysis.
deferasirox
(Deferasirox)
Teva Pharmaceuticals Inc
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.
deferasirox
(deferasirox)
Bionpharma Inc.
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for patients aged 10 and older with non-transfusion-dependent thalassemia syndromes who have specific liver iron levels and serum ferritin. Its safety with other iron chelation therapies is not established.
deferasirox
(Deferasirox)
Ascend Laboratories, LLC
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.
deferasirox
(Deferasirox)
Actavis Pharma, Inc.
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron and serum ferritin levels.
deferasirox oral granules
(deferasirox)
EPIC PHARMA, LLC
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 years and older with specific iron levels.
deferasorox
(Deferasirox)
MSN LABORATORIES PRIVATE LIMITED
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration criteria. Safety with other iron chelation therapies is not established.
deferasorox
(Deferasirox)
Novadoz Pharmaceuticals LLC
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, as well as for those aged 10 and older with non-transfusion dependent thalassemia syndromes, if specific liver iron concentration and serum ferritin levels are met.
feraheme
(ferumoxytol)
AMAG Pharmaceuticals, Inc.
Usage: Feraheme is indicated for treating iron deficiency anemia (IDA) in adult patients who are intolerant to oral iron, have had an unsatisfactory response to oral iron, or have chronic kidney disease (CKD).
ferric citrate
(Ferric Citrate)
Mylan Pharmaceuticals Inc.
Usage: Ferric citrate tablets are indicated for controlling serum phosphorus levels in adults with chronic kidney disease on dialysis, and for treating iron deficiency anemia in adults with chronic kidney disease not on dialysis.

Medications for Iron Deficiency Anemia

auryxia

deferasirox

deferasirox

deferasirox

deferasirox

deferasirox oral granules

deferasorox

deferasorox

feraheme

ferric citrate